Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pubertal metrorrhagia

C Duflos-Cohade1, M Amandruz, E Thibaud

  • 1Pediatric Endocrinology Unit, Hôpital Necker-Enfants Malades, Paris, France.

Journal of Pediatric and Adolescent Gynecology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of physicians' resilience level during the COVID-19 pandemic.

Translational psychiatry·2021
Same author

Analysis of delays in the prescription of oseltamivir in hospitals and potential for improvement.

Medecine et maladies infectieuses·2018
Same author

Breast diseases in adolescents.

Endocrine development·2012
Same author

[Juvenile granulosa-cell tumor: clinical and molecular expression].

Gynecologie, obstetrique & fertilite·2009
Same author

Emergency management and conservative surgery of ovarian torsion in children: a report of 40 cases.

Journal of pediatric and adolescent gynecology·2008
Same author

Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia.

The Journal of clinical endocrinology and metabolism·2007
Same journal

A Novel TP63 Mutation in a Patient with Premature Ovarian Insufficiency Type 21: Clinical Phenotype and Diagnostic Challenges.

Journal of pediatric and adolescent gynecology·2026
Same journal

From PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications for Adolescent Gynecologic Care.

Journal of pediatric and adolescent gynecology·2026
Same journal

GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns.

Journal of pediatric and adolescent gynecology·2026
Same journal

Breaking Barriers: Assessing the Educational and Reproductive Health Implications of Period Poverty Among Secondary School Girls.

Journal of pediatric and adolescent gynecology·2026
Same journal

Clinical Spectrum, Morphometrics, and Management of Perineal Cleft in Female Children.

Journal of pediatric and adolescent gynecology·2026
Same journal

Abdominoperineal reconstruction of the high vagina in cloaca and urogenital sinus - A report in 25 girls.

Journal of pediatric and adolescent gynecology·2026
See all related articles

Pubertal metrorrhagia is most often caused by functional disorders. Hemostatic disorders require early hormone treatment, while severe functional cases need long-term medical and hormonal management due to high recurrence risk.

Area of Science:

  • Pediatric Gynecology
  • Adolescent Health
  • Hematology

Background:

  • Pubertal metrorrhagia is abnormal uterine bleeding during adolescence.
  • Understanding its causes and effective treatments is crucial for managing adolescent reproductive health.

Purpose of the Study:

  • To characterize pubertal metrorrhagia, including its clinical presentation and treatment based on severity.
  • To determine the frequency of different etiologies and the impact of hemostatic abnormalities.
  • To describe the characteristics of severe pubertal metrorrhagia.

Main Methods:

  • Retrospective review of 105 adolescent patient files from a pediatric gynecology consultation.
  • Classification of patients into three groups based on anemia severity (Hb levels).

Related Experiment Videos

  • Analysis of etiological factors, including functional disorders, hemostatic abnormalities, and tumors.

    • Main Results:

    • Functional disorders accounted for 83% of pubertal metrorrhagia cases.
    • Severe anemia (Hb < 8 g%) predominantly occurred during the first three menstrual cycles and was often functional (15/18 cases).
    • Hormonal treatment (progestin or estroprogestin) was effective, and curettage was never required.

    Conclusions:

    • Functional disorders are the most common cause of pubertal metrorrhagia.
    • Pre-existing hemostatic disorders require early hormone treatment before menarche.
    • Severe functional metrorrhagia necessitates long-term medical and hormonal treatment due to a high risk of recurrence.